We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
(+7%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$104M |
| 2 |
Apple
AAPL
|
+$60.7M |
| 3 |
Amazon
AMZN
|
+$47.5M |
| 4 |
American Express
AXP
|
+$28.7M |
| 5 |
Travelers Companies
TRV
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$28.1M |
| 3 |
Clorox
CLX
|
+$26.2M |
| 4 |
TJX Companies
TJX
|
+$24.8M |
| 5 |
McKesson
MCK
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.39% |
| 2 | Financials | 11.87% |
| 3 | Technology | 10.68% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
RTX Corp
RTX
$287B
| $5.32M | 0.13% |
84,859
-1,602
| -2% | -$92.9K |
|
177
CNX Resources
CNX
$4.85B
| $5.31M | 0.13% |
567,782
-239,057
| -30% | -$1.74M |
|
|
WWAV
178
DELISTED
The WhiteWave Foods Company
WWAV
| $5.25M | 0.13% |
+129,810
| New | +$4.93M |
|
179
Boeing
BA
$165B
| $5.22M | 0.13% |
+41,339
| New | +$5.13M |
|
|
FOLD
180
DELISTED
Amicus Therapeutics
FOLD
| $5.21M | 0.13% |
619,900
-144,100
| -19% | -$1.02M |
|
|
LXFT
181
DELISTED
Luxoft Holding, Inc.
LXFT
| $5.18M | 0.13% |
94,700
+6,440
| +7% | +$388K |
|
182
Lumen
LUMN
$6.53B
| $5.1M | 0.13% |
160,565
+52,933
| +49% | +$1.48M |
|
|
RSE
183
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $5.02M | 0.13% |
+274,362
| New | +$4.73M |
|
|
HAR
184
DELISTED
Harman International Industries
HAR
| $5M | 0.13% |
+56,513
| New | +$4.49M |
|
|
GAP
185
The Gap Inc
GAP
$6.84B
| $4.99M | 0.12% |
+170,788
| New | +$4.49M |
|
|
RAI
186
DELISTED
Reynolds American Inc
RAI
| $4.97M | 0.12% |
99,305
+38,005
| +62% | +$1.87M |
|
187
Vulcan Materials
VMC
$36.3B
| $4.97M | 0.12% |
47,313
+28,929
| +157% | +$2.74M |
|
|
TFCF
188
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $4.95M | 0.12% |
176,434
+163,596
| +1,274% | +$4.4M |
|
189
Toronto Dominion Bank
TD
$198B
| $4.92M | 0.12% |
114,246
+9,952
| +10% | +$384K |
|
|
APC
190
DELISTED
Anadarko Petroleum
APC
| $4.89M | 0.12% |
+105,611
| New | +$4.29M |
|
191
LKQ Corp
LKQ
$6.58B
| $4.87M | 0.12% |
+153,187
| New | +$4.27M |
|
|
ICPT
192
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.86M | 0.12% |
38,000
+4,200
| +12% | +$496K |
|
193
Kohl's
KSS
$2.03B
| $4.84M | 0.12% |
+104,437
| New | +$4.9M |
|
194
Elevance Health
ELV
$81.9B
| $4.83M | 0.12% |
+34,971
| New | +$4.67M |
|
195
Boston Scientific
BSX
$65.8B
| $4.79M | 0.12% |
256,088
+121,403
| +90% | +$2.13M |
|
|
ADT
196
DELISTED
ADT Corp
ADT
| $4.74M | 0.12% |
115,540
-23,917
| -17% | -$839K |
|
|
AFFX
197
DELISTED
Affymetrix Inc
AFFX
| $4.74M | 0.12% |
+340,000
| New | +$4.66M |
|
198
Enanta Pharmaceuticals
ENTA
$372M
| $4.73M | 0.12% |
162,000
+56,000
| +53% | +$1.56M |
|
199
Neurocrine Biosciences
NBIX
$17.7B
| $4.68M | 0.12% |
119,000
+7,000
| +6% | +$278K |
|
200
Ionis Pharmaceuticals
IONS
$9.35B
| $4.63M | 0.12% |
114,939
+14,454
| +14% | +$587K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2016 Portfolio in Review
As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.
- Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
- Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
- Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
- Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
- Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
- Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
- Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.
Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.